Healthcare

Image

Middle East and Africa Migraine Treatment Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Feb 2023
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Middle East and Africa Migraine Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 65.83 Million
Diagram Market Size (Forecast Year) USD 128.31 Million
Diagram CAGR %

Middle East and Africa Migraine Treatment Market, By Types (Episodic, Migraine with Aura, Chronic and Others), Treatment (Acute/Abortive Treatment, Preventive/Prophylactic Treatment, Non-Pharmacological Therapies and Devices), Route of Administration (Oral, Parenteral, Nasal Sprays and Others), Product Type (Prescription and Over The Counter), Type (Branded and Generic), End-User (Hospitals, Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) – Industry Trends and Forecast to 2030.

Middle East and Africa Migraine Treatment Market Analysis and Size

Migraine is a common and debilitating brain illness. Headache accounts for 4.4 percent of all primary care visits, nearly 5% of all medical hospital admissions, and more than 20% of neurology outpatient consultations. Migraine affects approximately 20% of people at some point in their lives, according to epidemiological research, 4.5% of Western Europe's population suffers from headaches at least 15 days per month, and studies in the Middle East and Africa suggest that approximately 1% of the world's population suffers from chronic migraine. The vast majority of medications on the market now are approved to treat the acute version of the illness with generic triptans serving as the primary therapy. With the advent of CGRP-based medicines and the acceptance of novel medication classes such as ditans, gepants and the reformulation of triptans for both chronic and episodic migraine, the industry is observing a shift in terms of significant R&D.

Data Bridge Market Research analyses that the migraine treatment market which is USD 65.828 million in 2022, is expected to reach USD 128.31 million by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Migraine Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015- 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Types (Episodic, Migraine with Aura, Chronic and Others), Treatment (Acute/Abortive Treatment, Preventive/ Prophylactic Treatment, Non-Pharmacological Therapies and Devices), Route of Administration (Oral, Parenteral, Nasal Sprays and Others), Product Type (Prescription and Over The Counter), Type (Branded and Generic), End User (Hospitals, Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others)

Countries Covered

Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

Market Players Covered

Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), Amgen Inc. (U.S.), GSK plc. (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Abbott (U.S.), Allodynic Therapeutics, LLC (U.S.), AOBiome (U.S.), AstraZeneca (U.K.), Aurobindo Pharma USA (U.S.), Bausch Health Companies Inc. (Canada), Biohaven Pharmaceuticals (U.S.), Boehringer Ingelheim International GmbH (Germany), Catalent, Inc (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Impel Pharmaceuticals Inc. (U.S.), H. Lundbeck A/S (Denmark), Merck & Co., Inc (U.S.)

Market Opportunities

  • Growing awareness regarding migraine

Market Definition

Migraine is a debilitating neurological disease characterized by recurrent severe throbbing head pain attacks lasting more than three days. Migraine affects approximately 15% of the population over their lifetime with women (18%) being more affected than men (8%). It has been dubbed the "seventh disabler" due to its significant impact on patients' quality of life (QOL).

Migraine Treatment Market Dynamics

Drivers

  •  Increase in migraine prevalence and diagnosis

An enormous increase in migraine cases is one of the key factors fuelling market expansion. Additionally, the industry is gaining from better migraine treatment reimbursement rules and the increased need for precision medications. The market is expanding due to rising demand for electrical nerve stimulators used to treat migraines and the anticipated approval of new classes of late-stage pipeline medications with higher clinical efficacy, such as the introduction of calcitonin gene-related peptide (CGRP) monoclonal antibodies.

  •  Significant progress is being made in the preventative treatment of chronic migraine

The important developments should force us to revaluate how we treat this terrible illness, encourage us to keep an eye out for new developments in clinical science, and remind us that only a coordinated clinical and scientific management approach will increase the identification of chronic migraines. The distinction between phenotypic and biological indicators sheds light on areas of clinical governance that have gone unnoticed. It is up to us to make sure that cutting-edge and evolving therapy options, including OBT-A and anti-CGRP monoclonal antibodies, are fully utilized within a larger preventative culture to significantly reduce the societal, monetary and individual costs of this fatal illness.

Opportunities

  • Growing awareness regarding migraine

The key factors influencing the growth of the Middle East and Africa migraine treatment market in the near future are the rising prevalence of migraines and the variety of available treatments. Many organisations, such as the American Headache and Migraine Association, are working to increase public awareness of migraine by creating programmes and offering patient support. These efforts aim to increase understanding of the condition and associated headache conditions. Many vendors will invest in migraine medications' research and development (R&D) due to the growing incidence of migraines and unmet needs in the Middle East and Africa migraine treatment market. As a result, during the forecast period of 2023 to 2030, the global market for migraine treatment is anticipated to expand.

Restraints/Challenges

  • Side effects associated with migraine treatment

The drop in clinical visits and procedural treatment of migraines due to social distance norms, limits of current migraine medicines, and alternative therapies such as homoeopathy are anticipated to hamper the market growth in the forecast period of 2023 to 2030.

This migraine treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the migraine treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Migraine Treatment Market

The neurologic manifestations of COVID-19 suggest that the virus may have entered the nervous system through the olfactory groove or the bloodstream. There is compelling evidence that COVID-19 mortality is linked to cardiac and pulmonary diseases. Furthermore, migraine increases the burden of vascular diseases, putting migraine sufferers at a higher risk of poor COVID-19 outcomes. Acute COVID-19 symptoms such as fever, sleep disturbance, and dehydration may precipitate a migraine attack. COVID-19 headaches were described as pulsating, pressing, or stabbing in quality were mostly bilateral, lasted longer, were resistant to analgesia and were more common in men. This makes migraine sufferers particularly vulnerable to the pandemic's chronic and indirect effects, such as low mood and post-viral fatigue. After the pandemic rising R&D spending resulting in massive pipeline products, as well as an increase in the prevalence of migraines with high unmet needs, are all contributing to the global growth of the migraine treatment market.

Recent Development

  • In 2022, According to Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc., Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, earned a favourable opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).. The 75 mg dose of Rimegepant (available as an orally dissolving tablet) is suggested for marketing authorization for the acute treatment of migraine with or without aura in adults and the preventative treatment for episodic migraine in adults who experience at least four migraine attacks per month.
  • In 2022, Elyxyb (celecoxib oral solution) is a novel fast-acting liquid from BioDelivery Sciences. It's one of the first FDA-approved ready-to-use oral treatments for individuals suffering from acute migraine with or without aura.

Middle East and Africa Migraine Treatment Market Scope

The migraine treatment market is segmented on the basis of types, treatment, route of administration, product, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

  • Episodic
  • Migraine with Aura
  • Chronic
  • Others 

Treatment

  • Acute/Abortive Treatment
  • Preventive/prophylactic Treatment 
  • Non-Pharmacological Therapies and Devices

Route of Administration

  • Oral
  • Parenteral

 Product

  • Prescription
  • Over The Counter

Type

  • Branded
  • Generic

 End-User

  • Hospitals
  • Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Migraine Treatment Market Regional Analysis/Insights

The migraine treatment market is analyzed and market size insights and trends are provided by country, type, treatment, route of administration, product, distribution channel and end-user as referenced above.

The countries covered in the migraine treatment market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

South Africa is dominating the Middle East and Africa migraine treatment market due to the sizable amount of businesses in this industry view the nation as a crucial manufacturing hub due to the advantages it provides. This gives the nation a significant manufacturing option in addition to being a significant consumer.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The migraine treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for migraine treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the migraine treatment market. The data is available for historic period 2011-2021.

Competitive Landscape and Migraine Treatment Market Share Analysis

The migraine treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to migraine treatment market.

Some of the major players operating in the migraine treatment market are:

  • Pfizer Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Amgen Inc. (U.S.)
  • GSK plc. (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Abbott (U.S.)
  • Allodynic Therapeutics, LLC (U.S.)
  • AOBiome (U.S.)
  • AstraZeneca (U.K.)
  • Aurobindo Pharma USA (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Biohaven Pharmaceuticals (U.S.)
  • Boehringer Ingelheim International GmbH (Germany)
  • Catalent, Inc (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Impel Pharmaceuticals Inc. (U.S.)
  • H. Lundbeck A/S (Denmark)
  • Merck & Co., Inc (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The migraine treatment market value is USD 65.828 million in 2022.
The migraine treatment market is projected to grow at a CAGR of 8.7% during the forecast period of 2023-2030.
The depth of the anesthesia monitoring market is segmented on the basis of technology, mode of purchase, distribution channel, application, and end-user.
The countries covered in the depth of anesthesia monitoring market report are Saudi Arabia, the U.A.E, South Africa, Egypt, Israel, the Rest of the Middle East, and Africa (MEA) as part of the Middle East and Africa (MEA).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials